The insulin dosage market in South Africa has demonstrated notable fluctuations from 2012 to 2022. Starting at $197.15 million in 2012, the market saw a general decline until 2014 with a slight bounce back in 2015, but overall, it maintained an oscillating trend with no significant upward momentum. The market ended at $185.79 million in 2022, reflecting the various economic and healthcare challenges faced over the years. The year-on-year variations reveal occasional rises, such as in 2021 which saw a 6.7% increase over 2020, but also declines, like in 2022 which dropped by 4.35% compared to 2021. Despite some growth years, the overall CAGR over the last five years has hovered around nearly flat, indicating a stagnating market in the medium term.
Future trends to watch for include the potential impact of new insulin formulations and delivery methods, government healthcare policies, and the economic environment which can significantly influence market size and growth. Additionally, trends in diabetes prevalence and management strategies could also drive demand and market dynamics moving forward.
How does South Africa rank in Insulin in Dosage Market Size Value?
| # | 24 Countries | US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 China | 5,142,200,000 | 2023 | +4.22% | +3.16% | View data |
| 2 | 2 Germany | 2,490,600,000 | 2023 | -2.64% | -0.27% | View data |
| 3 | 3 United Kingdom | 1,864,000,000 | 2023 | +0.081% | +0.91% | View data |
| 4 | 4 Canada | 1,369,700,000 | 2023 | +1.89% | +2.55% | View data |
| 5 | 5 Japan | 1,340,600,000 | 2023 | -14.34% | -8.01% | View data |
| 12 | 12 Greece | 290,110,000 | 2023 | +5.75% | +6.69% | View data |
| 13 | 13 Belgium | 260,730,000 | 2023 | +2.7% | +3.78% | View data |
| 14 | 14 South Africa | 196,340,000 | 2023 | +0.82% | +0.56% | |
| 15 | 15 Sweden | 179,060,000 | 2023 | -4.06% | -5.88% | View data |
| 16 | 16 Austria | 97,906,000 | 2023 | +0.53% | +0.26% | View data |
